CDX2 and cancer: Consistent with the high prevalence of MSI-high cancers in the CDX2-suppressed group, genes encoding for the MMR-associated proteins MSH2, MSH6, PMS2, and MLH1 were significantly more frequently mutated in this group compared with the non-CDX2 -suppressed group (Figure 4).